SG/CALL/GERRESHEIMER/115/0.1/21.03.25 Stock

Warrant

DE000SU74XB0

Real-time Boerse Frankfurt Warrants 05:01:13 2024-05-22 am EDT
0.74 EUR -12.94% Intraday chart for SG/CALL/GERRESHEIMER/115/0.1/21.03.25
Current month-29.17%
1 month-21.30%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-22 0.74 -12.94%
24-05-21 0.85 -15.84%
24-05-20 1.01 -5.61%
24-05-17 1.07 -9.32%
24-05-16 1.18 +3.51%

Real-time Boerse Frankfurt Warrants

Last update May 22, 2024 at 05:01 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying GERRESHEIMER AG
IssuerLogo Issuer Société Générale Société Générale
WKN SU74XB
ISINDE000SU74XB0
Date issued 2024-02-09
Strike 115
Maturity 2025-03-21 (304 Days)
Parity 10 : 1
Emission price 0.83
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.89
Lowest since issue 0.7
Spread 0.01
Spread %1.30%

Company Profile

Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of packaging of glass for medicines and cosmetics, such as pharmaceuticals jars, ampoules, injection vials, cartridges, perfume flacons and cream jars, as well as glass containers for the food and beverage industry. The Company operates approximately 40 production facilities in Europe, North America, South America and Asia.
Sector
-
More about the company

Ratings for Gerresheimer AG

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Gerresheimer AG

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
94.6 EUR
Average target price
133.8 EUR
Spread / Average Target
+41.46%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW